Literature DB >> 22380712

Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets.

Lada Klaić1, Richard I Morimoto, Richard B Silverman.   

Abstract

The natural product celastrol (1) possesses numerous beneficial therapeutic properties and affects numerous cellular pathways. The mechanism of action and cellular target(s) of celastrol, however, remain unresolved. While a number of studies have proposed that the activity of celastrol is mediated through reaction with cysteine residues, these observations have been based on studies with specific proteins or by in vitro analysis of a small fraction of the proteome. In this study, we have investigated the spatial and structural requirements of celastrol for the design of suitable affinity probes to identify cellular binding partners of celastrol. Although celastrol has several potential sites for modification, some of these were not synthetically amenable or yielded unstable analogues. Conversion of the carboxylic acid functionality to amides and long-chain analogues, however, yielded bioactive compounds that induced the heat shock response (HSR) and antioxidant response and inhibited Hsp90 activity. This led to the synthesis of biotinylated celastrols (23 and 24) that were used as affinity reagents in extracts of human Panc-1 cells to identify Annexin II, eEF1A, and β-tubulin as potential targets of celastrol.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22380712      PMCID: PMC3356480          DOI: 10.1021/cb200539u

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  52 in total

Review 1.  Protein aggregation in crowded environments.

Authors:  R John Ellis; Allen P Minton
Journal:  Biol Chem       Date:  2006-05       Impact factor: 3.915

2.  Actin microfilament aggregation induced by withaferin A is mediated by annexin II.

Authors:  Ryan R Falsey; Marilyn T Marron; G M Kamal B Gunaherath; Nikhil Shirahatti; Daruka Mahadevan; A A Leslie Gunatilaka; Luke Whitesell
Journal:  Nat Chem Biol       Date:  2005-12-11       Impact factor: 15.040

3.  Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.

Authors:  Haley Hieronymus; Justin Lamb; Kenneth N Ross; Xiao P Peng; Cristina Clement; Anna Rodina; Maria Nieto; Jinyan Du; Kimberly Stegmaier; Srilakshmi M Raj; Katherine N Maloney; Jon Clardy; William C Hahn; Gabriela Chiosis; Todd R Golub
Journal:  Cancer Cell       Date:  2006-09-28       Impact factor: 31.743

Review 4.  HSP90 and the chaperoning of cancer.

Authors:  Luke Whitesell; Susan L Lindquist
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

5.  Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid.

Authors:  Jeong-Hyung Lee; Tae Hyeon Koo; Hyunkyung Yoon; Haeng Sun Jung; Hui Zi Jin; Kyeong Lee; Young-Soo Hong; Jung Joon Lee
Journal:  Biochem Pharmacol       Date:  2006-09-18       Impact factor: 5.858

6.  Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents.

Authors:  Xiu Jun Wang; John D Hayes; C Roland Wolf
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

7.  Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.

Authors:  Huanjie Yang; Di Chen; Qiuzhi Cindy Cui; Xiao Yuan; Q Ping Dou
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

8.  A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells.

Authors:  Tao Zhang; Adel Hamza; Xianhua Cao; Bing Wang; Shuwen Yu; Chang-Guo Zhan; Duxin Sun
Journal:  Mol Cancer Ther       Date:  2008-01       Impact factor: 6.261

9.  Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.

Authors:  Sabiha Abbas; Anindita Bhoumik; Russell Dahl; Stefan Vasile; Stan Krajewski; Nicholas D P Cosford; Ze'ev A Ronai
Journal:  Clin Cancer Res       Date:  2007-11-15       Impact factor: 12.531

10.  Identification of elongation factor 1alpha as a potential associated binding partner for Akt2.

Authors:  Janet Lau; Laura A Castelli; Emme C K Lin; S Lance Macaulay
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.842

View more
  24 in total

1.  Taxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate site.

Authors:  Yi-Liang Liu; Steffen Lindert; Wei Zhu; Ke Wang; J Andrew McCammon; Eric Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

2.  Chemical and biological mechanisms of phytochemical activation of Nrf2 and importance in disease prevention.

Authors:  Aimee L Eggler; Sergey N Savinov
Journal:  Recent Adv Phytochem       Date:  2013-12-03

3.  Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer.

Authors:  Zi Liu; Liang Ma; Zhe-Sheng Wen; Zheng Hu; Fu-Qun Wu; Wei Li; Jinsong Liu; Guang-Biao Zhou
Journal:  Carcinogenesis       Date:  2013-11-30       Impact factor: 4.944

Review 4.  Protein homeostasis as a therapeutic target for diseases of protein conformation.

Authors:  Barbara Calamini; Richard I Morimoto
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

5.  Mevalonate-derived quinonemethide triterpenoid from in vitro roots of Peritassa laevigata and their localization in root tissue by MALDI imaging.

Authors:  Edieidia S Pina; Denise B Silva; Simone P Teixeira; Juliana S Coppede; Maysa Furlan; Suzelei C França; Norberto P Lopes; Ana Maria S Pereira; Adriana A Lopes
Journal:  Sci Rep       Date:  2016-03-04       Impact factor: 4.379

6.  Chondro-protective effects of celastrol on osteoarthritis through autophagy activation and NF-κB signaling pathway inhibition.

Authors:  Kai Feng; Hongfang Chen; Chen Xu
Journal:  Inflamm Res       Date:  2020-02-28       Impact factor: 4.575

Review 7.  Heat shock protein 90 inhibition and multi-target approach to maximize cardioprotection in ischaemic injury.

Authors:  Shant Der Sarkissian; Henry Aceros; Pierre-Marc Williams; Catherine Scalabrini; Mélanie Borie; Nicolas Noiseux
Journal:  Br J Pharmacol       Date:  2020-05-23       Impact factor: 8.739

8.  Localization of heat shock proteins in cerebral cortical cultures following induction by celastrol.

Authors:  Ari M Chow; Derek W F Tang; Asad Hanif; Ian R Brown
Journal:  Cell Stress Chaperones       Date:  2014-04-04       Impact factor: 3.667

9.  Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines.

Authors:  Shivaprasad H Venkatesha; Brian Astry; Siddaraju M Nanjundaiah; Hua Yu; Kamal D Moudgil
Journal:  Bioorg Med Chem       Date:  2012-07-07       Impact factor: 3.641

10.  The plant triterpenoid celastrol blocks PINK1-dependent mitophagy by disrupting PINK1's association with the mitochondrial protein TOM20.

Authors:  Conggang Zhang; Rongchun Wang; Zeyu Liu; Eric Bunker; Schuyler Lee; Michelle Giuntini; Douglas Chapnick; Xuedong Liu
Journal:  J Biol Chem       Date:  2019-03-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.